SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies

SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies

header-info

In the present study, we examined the effects of SIRPα variant mismatch on clinical outcomes in patients receiving allo-HSCT from HLA-matched related donors for lymphoid malignancies.